The Probiota 2022 conference brings together experts and leaders from global industries and academia to present top level scientific insights into the microbiome and Europe’s changing regulatory landscape.
Chr. Hansen is excited to be present at the physical event, of which the global bioscience leader is a proud diamond sponsor.
For the first time, its Human Health business unit participates in a joint collaboration with the new HMO division focusing on human milk oligosaccharides for premium infant formula.
“We are very pleased to connect with other industry professionals and discuss what’s new in the world of HMOs, probiotics and human microbiome,” says Veronika Müller-Wigger, Senior Manager Commercial Development, HMO Business Unit.
“We are particularly excited that our colleagues, Dr. Greg Leyer, Senior R&D Director Human Health, and Dr. Adam Baker, Science Director Human Health, will take the audience on a journey through the current status of gut-brain research, where they will share how we are building the complex roadmap for the gut-brain research at Chr. Hansen. We are also pleased to present six scientific posters diving into more detail on a number of exciting subjects,” adds Karoline Thorsoee Elmstroem, Director, Global Marketing, Human Health.
